TPG and Temasek contribute $80 million to Dr. Agarwal's Indian Eye Hospital Chain

Dr. Agarwal's Health Care said this week that it raised $80 million from existing investors Singapore's Temasek and U.S.-based TPG as the Indian eye hospital operator plans to double its hospital count...

Lupin Introduces Patient Support Programme, Jeet to Raise Awareness of Cardiovascular Disease among Patients

Lupin Limited (Lupin) announced the launch of Jeet, a patient support programme dedicated to heart health. The launch of the initiative coincides with India's 77th Independence Day, symbolising freedom from disease-related stress and a journey...

NPPA Modifies Guidelines for a Change in Manufacturer to Allow Existing Market Entity to Produce in its Own Plant

The National Pharmaceutical Pricing Authority (NPPA) has changed the limits in its rules for permitting manufacturers to change once the retail pricing of formulations is approved, allowing the existing marketing entity to produce the medicine...

Aurobindo Pharma Arm Eugia Pharma Receives USFDA Nod For Icatibant Injection

The US Food & Drug Administration (USFDA) has given Takeda Pharmaceuticals USA Inc's wholly owned subsidiary company, Eugia Pharma Specialities Limited, final approval to produce and market Icatibant Injection, 30 mg/3 mL (10 mg/mL), Single-Dose...

Indian Hospital Industry in the Pink of Health with Rise in NCDs & Higher Medical Tourism Volumes: ICRA Reports

The rising incidence of non-communicable lifestyle diseases, rising per capita healthcare spending, rising levels of awareness, rising health insurance penetration, and rising medical tourism volumes all contribute to ICRA's...

Rs 5,000 Crore Initiative Set to Propel India's Pharma and MedTech Sector into Rapid Growth

The scheme intends to increase the pharmaceutical industry's worth from its present level of USD 50 billion to USD 130 billion by 2030. According to reputable government sources, the health ministry will soon unveil a comprehensive five-year plan...

WuXi Biologics and Boostimmune Sign an Agreement for Exclusive Research and Discovery Services

WuXi Biologics (WuXi Bio), a leading global CRDMO, and Boostimmune, a biotech company dedicated to developing next-generation anti-cancer therapies modulating the tumour immune microenvironment and ADCs to novel targets, announced the signing...

77 Years of Independence Day: An Outstanding Achievement in Cultural Resilience and Health Awareness

Today, India commemorates a truly special occasion as it marks the 77th anniversary of Thindependence Day. This unique celebration has evolved over the years from being a mere health-conscious event to a symbol of cultural resilience, unity,...

Lupin gets US FDA nod for Doxycycline Hyclate Delayed-Release Tablets USP

Lupin Limited announced that it has received FDA approval for its Abbreviated New Drug Application for doxycycline hyclate delayed-release tablets USP, 50 mg, 60 mg, 75 mg, 80 mg, 100 mg, 120 mg, 150 mg, and 200 mg, to market a generic equivalent...

Exor Acquires a 15% Stake in Philips for Approximately $2.8 Billion

Philips announced earlier this week that Dutch investment firm Exor NV has acquired a 15% stake in the company for approximately 2.6 billion euros ($2.84 billion)...

© 2025 India Pharma Outlook. All Rights Reserved.